Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Assets: 2009-2025

Historic Assets for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $3.4 billion.

  • Prestige Consumer Healthcare's Assets rose 3.78% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year increase of 3.78%. This contributed to the annual value of $3.4 billion for FY2025, which is 2.53% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Assets stood at $3.4 billion for Q3 2025, which was up 0.31% from $3.4 billion recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Assets registered a high of $3.7 billion during Q4 2022, and its lowest value of $3.3 billion during Q2 2024.
  • In the last 3 years, Prestige Consumer Healthcare's Assets had a median value of $3.3 billion in 2023 and averaged $3.4 billion.
  • Its Assets has fluctuated over the past 5 years, first rose by 7.04% in 2022, then dropped by 10.93% in 2023.
  • Prestige Consumer Healthcare's Assets (MRQ) stood at $3.7 billion in 2021, then rose by 2.47% to $3.7 billion in 2022, then decreased by 10.93% to $3.3 billion in 2023, then decreased by 0.31% to $3.3 billion in 2024, then increased by 3.39% to $3.4 billion in 2025.
  • Its Assets was $3.4 billion in Q3 2025, compared to $3.4 billion in Q2 2025 and $3.4 billion in Q1 2025.